0001881431-24-000001.txt : 20241211 0001881431-24-000001.hdr.sgml : 20241211 20241211134515 ACCESSION NUMBER: 0001881431-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241211 DATE AS OF CHANGE: 20241211 EFFECTIVENESS DATE: 20241211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aarvik Therapeutics, Inc. CENTRAL INDEX KEY: 0001881431 ORGANIZATION NAME: IRS NUMBER: 852895031 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-531747 FILM NUMBER: 241541112 BUSINESS ADDRESS: STREET 1: 34391 TUPELO STREET CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 650 703-2498 MAIL ADDRESS: STREET 1: 34391 TUPELO STREET CITY: FREMONT STATE: CA ZIP: 94555 D 1 primary_doc.xml X0708 D LIVE 0001881431 Aarvik Therapeutics, Inc. 31363 Medallion Drive Hayward CA CALIFORNIA 94544 408 741-1889 DELAWARE Aarkus Therapeutics Inc. None Corporation true 2020 Jagath Reddy Junutula c/o Aarvik Therapeutics, Inc. 31363 Medallion Drive Hayward CA CALIFORNIA 94544 Executive Officer Director Anula Jayasuriya c/o Aarvik Therapeutics, Inc. 31363 Medallion Drive Hayward CA CALIFORNIA 94544 Director Richard Scheller c/o Aarvik Therapeutics, Inc. 31363 Medallion Drive Hayward CA CALIFORNIA 94544 Director Sachdev Sidhu c/o Aarvik Therapeutics, Inc. 31363 Medallion Drive Hayward CA CALIFORNIA 94544 Director Ram Kalakoti Reddy c/o Aarvik Therapeutics, Inc. 31363 Medallion Drive Hayward CA CALIFORNIA 94544 Director Pharmaceuticals Decline to Disclose 06b false 2024-11-04 false true false 0 15000000 1165000 13835000 false 5 0 0 0 false Aarvik Therapeutics, Inc. Jagath Reddy Junutula Jagath Reddy Junutula Chief Executive Officer 2024-12-10